In vivo CRISPR Screening for Modifiers of Mutant Huntingtin Levels

Women’s Council Recipient
Myriam Heiman, Ph.D.
Massachusetts Institute of Technology

Huntington’s disease (HD) is an incurable brain disease that afflicts roughly 1 in every 10,000 people in the United States. HD is associated with movement problems, cognitive deficits, and psychiatric symptoms. HD most often strikes in middle age and leads to death in 10-20 years after symptom onset. Only symptomatic therapies exist to treat HD, and they are targeted to movement abnormalities, and do not help much with cognitive deficits or psychiatric symptoms. None of the existing therapies can stop of the progression of HD. Thus there is a clear need for new therapeutics that can stop the halt of HD, and even to reverse its course. Recent brain research studies have offered some hope. These studies have shown that lowering the levels of the mutant HD DNA product can halt and even reverse the progression of HD. Armed with this knowledge, we hope to identify other genes in DNA that can lead to lowered levels of the HD DNA product. To do so, we will conduct a genetic screen – systematically asking, gene by gene across all of the DNA, which genes can lower the mutant HD DNA product. Once identified, genes that we show lead to lower HD DNA product levels will be promising new therapeutic  targets.

Other Grants

Lindsay M. De Biase, Ph.D., University of California Los Angeles
The role of microglial lysosomes in selective neuronal vulnerability
Synapses, the sites of signaling between neurons in the brain, play essential roles in learning, memory, and the health of neurons themselves. An enduring mystery is why some neurons are…
How the nervous system constructs internal models of the external world
As animals navigate their environments, they construct internal models of the external sensory world and use these models to guide their behavior. This ability to incorporate ongoing sensory stimuli into…
Xiaojing Gao, Ph.D., Stanford University
When Neural Circuits Meet Molecular Circuits: Quantitative Genetic Manipulation with Single-cell Consistency
Cells are the building blocks of our bodies. We get sick when the cells “misbehave”. The way modern gene therapies work is to introduce genes, fragments of DNA molecules that…
Rafiq Huda, Ph.D., Rutgers University
Conducting the orchestra of movement—functional role of striatal astrocytes in health and disease
Movement requires coordinated activity across a large brain-wide network. The striatum is a particularly important part of this circuit; it integrates motor-related information from many distinct brain regions to regulate…